Akanda Corp. (NASDAQ:AKAN – Get Free Report) saw a significant decrease in short interest during the month of March. As of March 13th, there was short interest totaling 16,554 shares, a decrease of 34.3% from the February 26th total of 25,178 shares. Based on an average daily volume of 73,209 shares, the short-interest ratio is currently 0.2 days. Approximately 0.9% of the company’s stock are sold short.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Akanda in a research report on Monday, January 12th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
Check Out Our Latest Stock Analysis on AKAN
Akanda Stock Down 13.7%
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Further Reading
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
